Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Molecular Pain
Published in: Molecular Pain 1/2011

Open Access 01-12-2011 | Research

Transcription factors Sp1 and Sp4 regulate TRPV1 gene expression in rat sensory neurons

Authors: Catherine Chu, Kathryn Zavala, Atefeh Fahimi, Jessica Lee, Qing Xue, Helge Eilers, Mark A Schumacher

Published in: Molecular Pain | Issue 1/2011

Login to get access

Abstract

Background

The capsaicin receptor, transient receptor potential vanilloid type -1 (TRPV1) directs complex roles in signal transduction including the detection of noxious stimuli arising from cellular injury and inflammation. Under pathophysiologic conditions, TRPV1 mRNA and receptor protein expression are elevated in dorsal root ganglion (DRG) neurons for weeks to months and is associated with hyperalgesia. Building on our previous isolation of a promoter system for the rat TRPV1 gene, we investigated the proximal TRPV1 P2-promoter by first identifying candidate Sp1-like transcription factors bound in vivo to the P2-promoter using chromatin immunoprecipitation (ChIP) assay. We then performed deletion analysis of GC-box binding sites, and quantified promoter activity under conditions of Sp1 / Sp4 over-expression versus inhibition/knockdown. mRNA encoding Sp1, Sp4 and TRPV1 were quantified by qRT-PCR under conditions of Sp1/Sp4 over-expression or siRNA mediated knockdown in cultured DRG neurons.

Results

Using ChIP analysis of DRG tissue, we demonstrated that Sp1 and Sp4 are bound to the candidate GC-box site region within the endogenous TRPV1 P2-promoter. Deletion of GC-box "a" or "a + b" within the P2- promoter resulted in a complete loss of transcriptional activity indicating that GC-box "a" was the critical site for promoter activation. Co-transfection of Sp1 increased P2-promoter activity in cultured DRG neurons whereas mithramycin-a, an inhibitor of Sp1-like function, dose dependently blocked NGF and Sp1-dependent promoter activity in PC12 cells. Co-transfection of siRNA directed against Sp1 or Sp4 decreased promoter activity in DRG neurons and NGF treated PC12 cells. Finally, electroporation of Sp1 or Sp4 cDNA into cultures of DRG neurons directed an increase in Sp1/Sp4 mRNA and importantly an increase in TRPV1 mRNA. Conversely, combined si-RNA directed knockdown of Sp1/Sp4 resulted in a decrease in TRPV1 mRNA.

Conclusion

Based on these studies, we now propose a model of TRPV1 expression that is dependent on Sp1-like transcription factors with Sp4 playing a predominant role in activating TRPV1 RNA transcription in DRG neurons. Given that increases of TRPV1 expression have been implicated in a wide range of pathophysiologic states including persistent painful conditions, blockade of Sp1-like transcription factors represents a novel direction in therapeutic strategies.
Appendix
Available only for authorised users
Literature
1.
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997,389(6653):816–824. 10.1038/39807PubMedCrossRef
2.
Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D: The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998,21(3):531–543. 10.1016/S0896-6273(00)80564-4PubMedCrossRef
3.
Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999,400(6743):452–457. 10.1038/22761PubMedCrossRef
4.
Premkumar LS, Ahern GP: Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000,408(6815):985–990. 10.1038/35050121PubMedCrossRef
5.
Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, Kim SH, Lee MG, Choi YH, Kim J, et al.: Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 2002,99(15):10150–10155. 10.1073/pnas.152002699PubMedCentralPubMedCrossRef
6.
Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000,288(5464):306–313. 10.1126/science.288.5464.306PubMedCrossRef
7.
Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, Harries MH, Latcham J, Clapham C, Atkinson K, et al.: Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000,405(6783):183–187. 10.1038/35012076PubMedCrossRef
8.
Winter J, Forbes CA, Sternberg J, Lindsay RM: Nerve growth factor (NGF) regulates adult rat cultured dorsal root ganglion neuron responses to the excitotoxin capsaicin. Neuron 1988,1(10):973–981. 10.1016/0896-6273(88)90154-7PubMedCrossRef
9.
Michael GJ, Priestley JV: Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J Neurosci 1999,19(5):1844–1854.PubMed
10.
Koltzenburg M: The changing sensitivity in the life of the nociceptor. Pain 1999, (Suppl 6):S93–102.
11.
Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ: p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 2002,36(1):57–68. 10.1016/S0896-6273(02)00908-XPubMedCrossRef
12.
Amaya F, Shimosato G, Nagano M, Ueda M, Hashimoto S, Tanaka Y, Suzuki H, Tanaka M: NGF and GDNF differentially regulate TRPV1 expression that contributes to development of inflammatory thermal hyperalgesia. Eur J Neurosci 2004, 20: 2303–2310. 10.1111/j.1460-9568.2004.03701.xPubMedCrossRef
13.
Petruska JC, Mendell LM: The many functions of nerve growth factor: multiple actions on nociceptors. Neurosci Lett 2004, 361: 168–171. 10.1016/j.neulet.2003.12.012PubMedCrossRef
14.
Xue Q, Jong B, Chen T, Schumacher MA: Transcription of rat TRPV1 utilizes a dual promoter system that is positively regulated by nerve growth factor. J Neurochem 2007,101(1):212–222.PubMedCrossRef
15.
Sapetschnig A, Koch F, Rischitor G, Mennenga T, Suske G: Complexity of translationally controlled transcription factor Sp3 isoform expression. J Biol Chem 2004,279(40):42095–42105. Epub 42004 Jul 42099 10.1074/jbc.M404989200PubMedCrossRef
16.
Ramos B, Gaudilliere B, Bonni A, Gill G: Transcription factor Sp4 regulates dendritic patterning during cerebellar maturation. Proc Natl Acad Sci USA 2007,104(23):9882–9887. 10.1073/pnas.0701946104PubMedCentralPubMedCrossRef
17.
Schmittgen TD, Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008,3(6):1101–1108. 10.1038/nprot.2008.73PubMedCrossRef
18.
Bai G, Kusiak JW: Nerve growth factor up-regulates the N-methyl-D-aspartate receptor subunit 1 promoter in PC12 cells. J Biol Chem 1997,272(9):5936–5942. 10.1074/jbc.272.9.5936PubMedCrossRef
19.
Liu A, Prenger MS, Norton DD, Mei L, Kusiak JW, Bai G: Nerve growth factor uses Ras/ERK and phosphatidylinositol 3-kinase cascades to up-regulate the N-methyl-D-aspartate receptor 1 promoter. J Biol Chem 2001,276(48):45372–45379. 10.1074/jbc.M105399200PubMedCrossRef
20.
Sobue S, Hagiwara K, Banno Y, Tamiya-Koizumi K, Suzuki M, Takagi A, Kojima T, Asano H, Nozawa Y, Murate T: Transcription factor specificity protein 1 (Sp1) is the main regulator of nerve growth factor-induced sphingosine kinase 1 gene expression of the rat pheochromocytoma cell line, PC12. J Neurochem 2005,95(4):940–949. 10.1111/j.1471-4159.2005.03399.xPubMedCrossRef
21.
Tai TC, Wong-Faull DC, Claycomb R, Wong DL: Nerve growth factor regulates adrenergic expression. Mol Pharmacol 2006,70(5):1792–1801. Epub 2006 Aug 1722 10.1124/mol.106.026237PubMedCrossRef
22.
Zhang J, Wang S, Wesley RA, Danner RL: Adjacent sequence controls the response polarity of nitric oxide-sensitive Sp factor binding sites. J Biol Chem 2003,278(31):29192–29200. Epub 22003 May 29119 10.1074/jbc.M213043200PubMedCrossRef
23.
Kazi AA, Jones JM, Koos RD: Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Mol Endocrinol 2005,19(8):2006–2019. Epub 2005 Mar 2017 10.1210/me.2004-0388PubMedCrossRef
24.
Kubat NJ, Tran RK, McAnany P, Bloom DC: Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression. J Virol 2004,78(3):1139–1149. 10.1128/JVI.78.3.1139-1149.2004PubMedCentralPubMedCrossRef
25.
Hagen G, Muller S, Beato M, Suske G: Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res 1992,20(21):5519–5525. 10.1093/nar/20.21.5519PubMedCentralPubMedCrossRef
26.
Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, Miller DM: Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 1991,88(5):1613–1621. 10.1172/JCI115474PubMedCentralPubMedCrossRef
27.
Wohlert SE, Kunzel E, Machinek R, Mendez C, Salas JA, Rohr J: The structure of mithramycin reinvestigated. J Nat Prod 1999,62(1):119–121. 10.1021/np980355kPubMedCrossRef
28.
Yuan P, Wang L, Wei D, Zhang J, Jia Z, Li Q, Le X, Wang H, Yao J, Xie K: Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer. Cancer 2007,110(12):2682–2690. 10.1002/cncr.23092PubMedCrossRef
29.
Fountain SJ, Cheong A, Li J, Dondas NY, Zeng F, Wood IC, Beech DJ: Kv1.5 potassium channel gene regulation by Sp1 transcription factor and oxidative stress. Am J Physiol Heart Circ Physiol 2007,293(5):H2719–2725. 10.1152/ajpheart.00637.2007PubMedCrossRef
30.
Dynan WS, Tjian R: Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell 1983,32(3):669–680. 10.1016/0092-8674(83)90053-3PubMedCrossRef
31.
Black AR, Black JD, Azizkhan-Clifford J: Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 2001,188(2):143–160. 10.1002/jcp.1111PubMedCrossRef
32.
Ravasi T, Huber T, Zavolan M, Forrest A, Gaasterland T, Grimmond S, Hume DA: Systematic characterization of the zinc-finger-containing proteins in the mouse transcriptome. Genome Res 2003,13(6B):1430–1442.PubMedCentralPubMedCrossRef
33.
Li L, He S, Sun JM, Davie JR: Gene regulation by Sp1 and Sp3. Biochem Cell Biol 2004,82(4):460–471. 10.1139/o04-045PubMedCrossRef
34.
Saffer JD, Jackson SP, Annarella MB: Developmental expression of Sp1 in the mouse. Mol Cell Biol 1991,11(4):2189–2199.PubMedCentralPubMed
35.
Marin M, Karis A, Visser P, Grosveld F, Philipsen S: Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell 1997,89(4):619–628. 10.1016/S0092-8674(00)80243-3PubMedCrossRef
36.
Bouwman P, Gollner H, Elsasser HP, Eckhoff G, Karis A, Grosveld F, Philipsen S, Suske G: Transcription factor Sp3 is essential for post-natal survival and late tooth development. Embo J 2000,19(4):655–661. 10.1093/emboj/19.4.655PubMedCentralPubMedCrossRef
37.
Hitoshi S, Kusunoki S, Kanazawa I, Tsuji S: Dorsal root ganglia neuron-specific promoter activity of the rabbit beta-galactoside alpha1,2-fucosyltransferase gene. J Biol Chem 1999,274(1):389–396. 10.1074/jbc.274.1.389PubMedCrossRef
38.
Hung JJ, Wang YT, Chang WC: Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription. Mol Cell Biol 2006,26(5):1770–1785. 10.1128/MCB.26.5.1770-1785.2006PubMedCentralPubMedCrossRef
39.
Hagen G, Muller S, Beato M, Suske G: Sp1-mediated transcriptional activation is repressed by Sp3. Embo J 1994,13(16):3843–3851.PubMedCentralPubMed
40.
Zhu H, Nguyen VT, Brown AB, Pourhosseini A, Garcia AV, van Bilsen M, Chien KR: A novel, tissue-restricted zinc finger protein (HF-1b) binds to the cardiac regulatory element (HF-1b/MEF-2) in the rat myosin light-chain 2 gene. Mol Cell Biol 1993,13(7):4432–4444.PubMedCentralPubMed
41.
Lerner LE, Gribanova YE, Whitaker L, Knox BE, Farber DB: The rod cGMP-phosphodiesterase beta-subunit promoter is a specific target for Sp4 and is not activated by other Sp proteins or CRX. J Biol Chem 2002,277(29):25877–25883. Epub 22002 Apr 25879 10.1074/jbc.M201407200PubMedCrossRef
42.
Zhou X, Qyang Y, Kelsoe JR, Masliah E, Geyer MA: Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice. Genes Brain Behav 2007,6(3):269–276. Epub 2006 Aug 2007 10.1111/j.1601-183X.2006.00256.xPubMedCrossRef
43.
Zhou X, Long JM, Geyer MA, Masliah E, Kelsoe JR, Wynshaw-Boris A, Chien KR: Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization. Mol Psychiatry 2005,10(4):393–406. 10.1038/sj.mp.4001621PubMedCrossRef
44.
Supp DM, Witte DP, Branford WW, Smith EP, Potter SS: Sp4, a member of the Sp1-family of zinc finger transcription factors, is required for normal murine growth, viability, and male fertility. Developmental biology 1996,176(2):284–299. 10.1006/dbio.1996.0134PubMedCrossRef
45.
Gollner H, Bouwman P, Mangold M, Karis A, Braun H, Rohner I, Del Rey A, Besedovsky HO, Meinhardt A, van den Broek M, et al.: Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene. Genes to cells 2001,6(8):689–697. 10.1046/j.1365-2443.2001.00455.xPubMedCrossRef
46.
Nguyen-Tran VT, Kubalak SW, Minamisawa S, Fiset C, Wollert KC, Brown AB, Ruiz-Lozano P, Barrere-Lemaire S, Kondo R, Norman LW, et al.: A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages. Cell 2000,102(5):671–682. 10.1016/S0092-8674(00)00089-1PubMedCrossRef
47.
St Amand TR, Lu JT, Zamora M, Gu Y, Stricker J, Hoshijima M, Epstein JA, Ross JJ, Ruiz-Lozano P, Chien KR: Distinct roles of HF-1b/Sp4 in ventricular and neural crest cells lineages affect cardiac conduction system development. Dev Biol 2006,291(2):208–217. Epub 2006 Jan 2020 10.1016/j.ydbio.2005.10.018PubMedCrossRef
48.
Merchant JL, Du M, Todisco A: Sp1 phosphorylation by Erk 2 stimulates DNA binding. Biochem Biophys Res Commun 1999,254(2):454–461. 10.1006/bbrc.1998.9964PubMedCrossRef
49.
Bouwman P, Philipsen S: Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol 2002,195(1–2):27–38. 10.1016/S0303-7207(02)00221-6PubMedCrossRef
50.
51.
Zhuang ZY, Xu H, Clapham DE, Ji RR: Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 2004,24(38):8300–8309. 10.1523/JNEUROSCI.2893-04.2004PubMedCrossRef
52.
Stein AT, Ufret-Vincenty CA, Hua L, Santana LF, Gordon SE: Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol 2006,128(5):509–522. 10.1085/jgp.200609576PubMedCentralPubMedCrossRef
53.
Zhu W, Oxford GS: Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1. Mol Cell Neurosci 2007,34(4):689–700. Epub 2007 Jan 2024 10.1016/j.mcn.2007.01.005PubMedCentralPubMedCrossRef
54.
Winston J, Toma H, Shenoy M, Pasricha PJ: Nerve growth factor regulates VR-1 mRNA levels in cultures of adult dorsal root ganglion neurons. Pain 2001,89(2–3):181–186. 10.1016/S0304-3959(00)00370-5PubMedCrossRef
55.
Vaudry D, Stork PJ, Lazarovici P, Eiden LE: Signaling pathways for PC12 cell differentiation: making the right connections. Science 2002,296(5573):1648–1649. 10.1126/science.1071552PubMedCrossRef
56.
Amaya F, Oh-hashi K, Naruse Y, Iijima N, Ueda M, Shimosato G, Tominaga M, Tanaka Y, Tanaka M: Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons. Brain Res 2003, 963: 190–196. 10.1016/S0006-8993(02)03972-0PubMedCrossRef
57.
Eilers H, Trilk SL, Lee SY, Xue Q, Jong BE, Moff I, Levine JD, Schumacher MA: Isolation of an mRNA binding protein homologue that is expressed in nociceptors. Eur J Neurosci 2004,20(9):2283–2293. 10.1111/j.1460-9568.2004.03703.xPubMedCrossRef
58.
Citron BA, Dennis JS, Zeitlin RS, Echeverria V: Transcription factor Sp1 dysregulation in Alzheimer's disease. J Neurosci Res 2008,86(11):2499–2504. 10.1002/jnr.21695PubMedCrossRef
59.
Ryu H, Lee J, Zaman K, Kubilis J, Ferrante RJ, Ross BD, Neve R, Ratan RR: Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J Neurosci 2003,23(9):3597–3606.PubMed
60.
Fujimura N, Vacik T, Machon O, Vlcek C, Scalabrin S, Speth M, Diep D, Krauss S, Kozmik Z: Wnt-mediated down-regulation of Sp1 target genes by a transcriptional repressor Sp5. J Biol Chem 2007,282(2):1225–1237.PubMedCrossRef
61.
Treichel D, Becker MB, Gruss P: The novel transcription factor gene Sp5 exhibits a dynamic and highly restricted expression pattern during mouse embryogenesis. Mech Dev 2001,101(1–2):175–179. 10.1016/S0925-4773(00)00544-XPubMedCrossRef
Metadata
Title
Transcription factors Sp1 and Sp4 regulate TRPV1 gene expression in rat sensory neurons
Authors
Catherine Chu
Kathryn Zavala
Atefeh Fahimi
Jessica Lee
Qing Xue
Helge Eilers
Mark A Schumacher
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Molecular Pain / Issue 1/2011
Electronic ISSN: 1744-8069
DOI
https://doi.org/10.1186/1744-8069-7-44

Other articles of this Issue 1/2011

Molecular Pain 1/2011 Go to the issue

Research

EP1 receptor within the ventrolateral periaqueductal grey controls thermonociception and rostral ventromedial medulla cell activity in healthy and neuropathic rat

Research

Selective nociceptor activation in volunteers by infrared diode laser

Research

Antinociceptive effect of cyclic phosphatidic acid and its derivative on animal models of acute and chronic pain

Research

The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain

Research

Hyperalgesic activity of kisspeptin in mice

Short report

CFTR mediates noradrenaline-induced ATP efflux from DRG neurons